Follow-up (FU) of patients still alive in months from initial bronchoscopic treatment (IBT) until July 2014
| Carcinoid | Treatment (n) | Outcome (n) | Median FU (mo) | Range FU (mo) | Remarks |
|---|---|---|---|---|---|
| Typical (75) | IBT (38) | CR (33) | 120 | (73–241) | |
| Residue (3) | 168 | (140–205) | 1 unfit, 2 refused | ||
| Recurrence (2) | 10 and 63 | IBT—Recurrence | |||
| 98 and 29 | BT—July 2014 | ||||
| Surgery (37) | CR (35) | 129 | (60–267) | ||
| Recurrence (2) | 47 and 104 | IBT—Recurrence | |||
| 57 and 111 | Surgery—July 2014 | ||||
| Atypical (25) | IBT (5) | CR (5) | 109 | (83–170) | |
| Surgery (20) | CR (18) | 88.5 | (60–159) | ||
| Recurrence (2) | 116 and 198 | IBT—Recurrence | |||
| 113 and 79 | Surgery—July 2014 |
No residual tumour detected macroscopically (videobronchoscopy, high resolution CT) and microscopically (biopsy and brush specimens).
CR, complete remission; BT, bronchoscopic treatment.